Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

Keywords

MedicineSurrogate endpointInternal medicineHead and neck cancerClinical endpointOncologyRadiation therapyHead and neck squamous-cell carcinomaSurvival analysisConcomitantChemotherapyProportional hazards modelRandomized controlled trial

Affiliated Institutions

Related Publications

Photodynamic therapy and the treatment of head and neck neoplasia

M. A. Biel

Abstract Objective : To present the theory, technique, and results of photodynamic therapy for the treatment of oral, laryngeal, and head and neck cancers. Study Design : Retros...

1998 The Laryngoscope 122 citations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen , Denis Soulières , Christophe Le Tourneau +97 more

There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and manageabl...

2018 The Lancet 1593 citations

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David G. Pfister , Sharon Spencer , David J. Adelstein +34 more

Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment...

2020 Journal of the National Comprehensive... 1285 citations

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17

Víctor A. Marcial , Thomas F. Pajak , Mohammed Mohiuddin +7 more

One hundred twenty-four eligible patients with advanced mucosal squamous cell carcinoma of the head and neck were entered into a pilot study of concomitant cisplatin (100 mg/m2 ...

1990 Cancer 191 citations

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

David J. Adelstein , Yi Li , George L. Adams +5 more

Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable squamous cell ...

2002 Journal of Clinical Oncology 1729 citations

Publication Info

Year: 2009
Type: review
Volume: 10
Issue: 4
Pages: 341-350
Citations: 161
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

161

OpenAlex

Cite This

APA Style

                            
                                
                                    Stefan Michiels, 
                                
                                    Aurélie Le Maître, 
                                
                                    Marc Buyse
                                
                                et al.
                            
                            (2009). 
                            Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. 
                            The Lancet Oncology
                            , 10
                            (4)
                            , 341-350.
                            https://doi.org/10.1016/s1470-2045(09)70023-3
                        

Identifiers

DOI: 10.1016/s1470-2045(09)70023-3